578 related articles for article (PubMed ID: 25673719)
1. An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infection.
Zanin M; Keck ZY; Rainey GJ; Lam CY; Boon AC; Rubrum A; Darnell D; Wong SS; Griffin Y; Xia J; Webster RG; Webby R; Johnson S; Foung S
J Virol; 2015 Apr; 89(8):4549-61. PubMed ID: 25673719
[TBL] [Abstract][Full Text] [Related]
2. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and protective efficacy of cold-adapted X-31 live attenuated pre-pandemic H5N1 influenza vaccines.
Jang YH; Jung EJ; Byun YH; Lee KH; Lee EY; Lee YJ; Seong BL
Vaccine; 2013 Jul; 31(33):3339-46. PubMed ID: 23742997
[TBL] [Abstract][Full Text] [Related]
4. A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms.
Tan Y; Ng Q; Jia Q; Kwang J; He F
J Virol; 2015 Apr; 89(7):3712-22. PubMed ID: 25609802
[TBL] [Abstract][Full Text] [Related]
5. Divergent Requirement of Fc-Fcγ Receptor Interactions for
Wang S; Ren H; Jiang W; Chen H; Hu H; Chen Z; Zhou P
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331095
[TBL] [Abstract][Full Text] [Related]
6. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
Mahmood K; Bright RA; Mytle N; Carter DM; Crevar CJ; Achenbach JE; Heaton PM; Tumpey TM; Ross TM
Vaccine; 2008 Oct; 26(42):5393-9. PubMed ID: 18706956
[TBL] [Abstract][Full Text] [Related]
7. Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets.
Forrest HL; Khalenkov AM; Govorkova EA; Kim JK; Del Giudice G; Webster RG
Vaccine; 2009 Jun; 27(31):4187-95. PubMed ID: 19406182
[TBL] [Abstract][Full Text] [Related]
8. Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections.
Liu G; Song L; Reiserova L; Trivedi U; Li H; Liu X; Noah D; Hou F; Weaver B; Tussey L
Vaccine; 2012 Nov; 30(48):6833-8. PubMed ID: 23000130
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of passive immunization with monoclonal antibodies in animal models of H5N1 highly pathogenic avian influenza virus infection.
Itoh Y; Yoshida R; Shichinohe S; Higuchi M; Ishigaki H; Nakayama M; Pham VL; Ishida H; Kitano M; Arikata M; Kitagawa N; Mitsuishi Y; Ogasawara K; Tsuchiya H; Hiono T; Okamatsu M; Sakoda Y; Kida H; Ito M; Quynh Mai L; Kawaoka Y; Miyamoto H; Ishijima M; Igarashi M; Suzuki Y; Takada A
PLoS Pathog; 2014 Jun; 10(6):e1004192. PubMed ID: 24945244
[TBL] [Abstract][Full Text] [Related]
10. Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge.
Nachbagauer R; Shore D; Yang H; Johnson SK; Gabbard JD; Tompkins SM; Wrammert J; Wilson PC; Stevens J; Ahmed R; Krammer F; Ellebedy AH
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899095
[TBL] [Abstract][Full Text] [Related]
11. Properties and therapeutic efficacy of broadly reactive chimeric and humanized H5-specific monoclonal antibodies against H5N1 influenza viruses.
Zheng Q; Xia L; Wu WL; Zheng Z; Huo Y; Wu J; Liu Y; Yu H; Chen Y; Lau SY; Chen H; Luo W; Xia N
Antimicrob Agents Chemother; 2011 Apr; 55(4):1349-57. PubMed ID: 21245446
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza.
Simmons CP; Bernasconi NL; Suguitan AL; Mills K; Ward JM; Chau NV; Hien TT; Sallusto F; Ha do Q; Farrar J; de Jong MD; Lanzavecchia A; Subbarao K
PLoS Med; 2007 May; 4(5):e178. PubMed ID: 17535101
[TBL] [Abstract][Full Text] [Related]
13. Site-Specific Glycan-Masking/Unmasking Hemagglutinin Antigen Design to Elicit Broadly Neutralizing and Stem-Binding Antibodies Against Highly Pathogenic Avian Influenza H5N1 Virus Infections.
Chen TH; Yang YL; Jan JT; Chen CC; Wu SC
Front Immunol; 2021; 12():692700. PubMed ID: 34335603
[TBL] [Abstract][Full Text] [Related]
14. Humanized antibodies with broad-spectrum neutralization to avian influenza virus H5N1.
Chen Y; Luo W; Wu WL; Fang Z; Xia L; Gui X; Chen Y; Chen H; Shih JW; Xia N
Antiviral Res; 2010 Jul; 87(1):81-4. PubMed ID: 20450935
[TBL] [Abstract][Full Text] [Related]
15. Broadening the H5N3 Vaccine Immunogenicity against H5N1 Virus by Modification of Neutralizing Epitopes.
Rajesh Kumar S; Chelvaretnam S; Tan Y; Prabakaran M
Viruses; 2017 Dec; 10(1):. PubMed ID: 29295514
[TBL] [Abstract][Full Text] [Related]
16. Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.
Marjuki H; Mishin VP; Chai N; Tan MW; Newton EM; Tegeris J; Erlandson K; Willis M; Jones J; Davis T; Stevens J; Gubareva LV
J Virol; 2016 Dec; 90(23):10446-10458. PubMed ID: 27630240
[TBL] [Abstract][Full Text] [Related]
17. An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza viruses.
Oh HL; Akerström S; Shen S; Bereczky S; Karlberg H; Klingström J; Lal SK; Mirazimi A; Tan YJ
J Virol; 2010 Aug; 84(16):8275-86. PubMed ID: 20519402
[TBL] [Abstract][Full Text] [Related]
18. A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets.
Giles BM; Ross TM
Vaccine; 2011 Apr; 29(16):3043-54. PubMed ID: 21320540
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in Mice.
Wong G; Qiu X; Ebihara H; Feldmann H; Kobinger GP
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S435-42. PubMed ID: 26022441
[TBL] [Abstract][Full Text] [Related]
20. Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice.
Harada Y; Ninomiya-Mori A; Takahashi Y; Shirakura M; Kishida N; Kageyama T; Tada Y; Tashiro M; Odagiri T
Vaccine; 2011 Oct; 29(46):8330-7. PubMed ID: 21911027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
